BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24878455)

  • 1. A systematic review and meta-analysis of the clinicopathologic characteristics of cystic versus solid pancreatic neuroendocrine neoplasms.
    Koh YX; Chok AY; Zheng HL; Tan CS; Goh BK
    Surgery; 2014 Jul; 156(1):83-96.e2. PubMed ID: 24878455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The associations between serum high-density lipoprotein cholesterol levels and malignant behavior in pancreatic neuroendocrine neoplasms.
    Quan L; Liu Y; Cui W; Wang X; Zhang W; Wang Z; Guo C; Lu C; Hu F; Chen X
    Lipids Health Dis; 2022 Jul; 21(1):58. PubMed ID: 35842659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic pancreatic neuroendocrine tumors: A distinctive subgroup with indolent biological behavior? A systematic review and meta-analysis.
    Zhu JK; Wu D; Xu JW; Huang X; Jiang YY; Edil BH; Li M; Hu SY; Zhan HX
    Pancreatology; 2019 Jul; 19(5):738-750. PubMed ID: 31160191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. The large experience of the Spanish National Tumor Registry (RGETNE).
    Martin-Perez E; Capdevila J; Castellano D; Jimenez-Fonseca P; Salazar R; Beguiristain-Gomez A; Alonso-Orduña V; Martinez Del Prado P; Villabona-Artero C; Diaz-Perez JA; Monleon A; Marazuela M; Pachon V; Sastre-Valera J; Sevilla I; Castaño A; Garcia-Carbonero R
    Neuroendocrinology; 2013; 98(2):156-68. PubMed ID: 23988576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine tumors of the pancreas: Degree of cystic component predicts prognosis.
    Cloyd JM; Kopecky KE; Norton JA; Kunz PL; Fisher GA; Visser BC; Dua MM; Park WG; Poultsides GA
    Surgery; 2016 Sep; 160(3):708-13. PubMed ID: 27216830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections.
    Boninsegna L; Panzuto F; Partelli S; Capelli P; Delle Fave G; Bettini R; Pederzoli P; Scarpa A; Falconi M
    Eur J Cancer; 2012 Jul; 48(11):1608-15. PubMed ID: 22129889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicoradiological Factors Predicting Lymph Node Metastasis in Patients with Nonfunctioning Pancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis.
    Jeong B; Heo S; Kim DW; Kim KW
    Neuroendocrinology; 2024; 114(2):111-119. PubMed ID: 37703849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of morphological features in lymph node metastasis between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomas.
    Takahashi D; Kojima M; Morisue R; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Gotohda N; Ikeda M; Ochiai A
    Pancreatology; 2020 Jul; 20(5):936-943. PubMed ID: 32553561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Effect of the Total Number of Examined Lymph Nodes on N Staging and Survival in Pancreatic Neuroendocrine Neoplasms.
    Zhang X; Lu L; Liu P; Cao F; Wei Y; Ma L; Gong P
    Pancreas; 2018 Feb; 47(2):183-189. PubMed ID: 29329160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of 100 consecutive cases of resectable pancreatic neuroendocrine neoplasms: clinicopathological characteristics and long-term outcomes.
    Cheng Y; Zhan H; Wang L; Xu J; Zhang G; Zhang Z; Hu S
    Front Med; 2016 Dec; 10(4):444-450. PubMed ID: 27757796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between jaundice and poorly differentiated pancreatic neuroendocrine neoplasms (Ki67 index > 55.0%).
    Liu Y; Wang J; Zhou H; Wei Z; Wang J; Wang Z; Chen X
    BMC Gastroenterol; 2023 Dec; 23(1):436. PubMed ID: 38087239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic Pancreatic Neuroendocrine Tumors Represent a Distinct Clinical Entity with Less Aggressive Biological Behaviors.
    Cheng Y; Wu D; Wang L; Liu H; Xiong Y; Xu J; Hu S; Zhan H
    J Surg Res; 2021 Apr; 260():134-140. PubMed ID: 33340866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The number of positive lymph node is a better predictor of survival than the lymph node metastasis status for pancreatic neuroendocrine neoplasms: A retrospective cohort study.
    Zhang X; Lu L; Shang Y; Liu P; Wei Y; Ma L; Gong P
    Int J Surg; 2017 Dec; 48():142-148. PubMed ID: 29107188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic pancreatic neuroendocrine tumors: A more favorable lesion?
    Carr RA; Bletsis P; Roch AM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM; Ceppa EP
    Pancreatology; 2019 Mar; 19(2):372-376. PubMed ID: 30704851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and meta-analysis on laparoscopic pancreatic resections for neuroendocrine neoplasms (PNENs).
    Tamburrino D; Partelli S; Renzi C; Crippa S; Muffatti F; Perali C; Parisi A; Randolph J; Fusai GK; Cirocchi R; Falconi M
    Expert Rev Gastroenterol Hepatol; 2017 Jan; 11(1):65-73. PubMed ID: 27781493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant potential of small pancreatic neuroendocrine neoplasm and its risk factors: A multicenter nationwide study.
    Paik WH; Lee HS; Lee KJ; Jang SI; Lee WJ; Hwang JH; Cho CM; Park CH; Han J; Woo SM; Jeong S; Chon HK; Kim TN; Lee JK; Han JH; Yoon JH; Kim YT; Cho JH
    Pancreatology; 2021 Jan; 21(1):208-214. PubMed ID: 33281058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient characteristics and clinical outcomes following initial surgical intervention for MEN1 associated pancreatic neuroendocrine tumours: A systematic review and exploratory meta-analysis of the literature.
    Ratnayake CBB; Loveday BP; Windsor JA; Lawrence B; Pandanaboyana S
    Pancreatology; 2019 Apr; 19(3):462-471. PubMed ID: 30894303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of prognosis between observation and surgical resection groups with small sporadic non-functional pancreatic neuroendocrine neoplasms without distant metastasis.
    Kurita Y; Hara K; Kuwahara T; Mizuno N; Okuno N; Haba S; Okuno M; Natsume S; Senda Y; Kubota K; Nakajima A; Niwa Y; Shimizu Y
    J Gastroenterol; 2020 May; 55(5):543-552. PubMed ID: 31858231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic pancreatic neuroendocrine tumors: a clinicopathologic study.
    Singhi AD; Chu LC; Tatsas AD; Shi C; Ellison TA; Fishman EK; Kawamoto S; Schulick RD; Wolfgang CL; Hruban RH; Edil BH
    Am J Surg Pathol; 2012 Nov; 36(11):1666-73. PubMed ID: 23073325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms.
    Gao Y; Gao H; Wang G; Yin L; Xu W; Peng Y; Wu J; Jiang K; Miao Y
    Sci Rep; 2018 May; 8(1):7271. PubMed ID: 29739948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.